Completed Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies NCT02315612 Conditions ALL, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, +32 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
Completed Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine NCT02996773 Conditions Actinomycetales Infections, Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, +52 more Locations The University of Arizona Cancer Center — Tucson, Arizona, United States View Trial Details
Completed Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma NCT01593696 Conditions ALL, B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +16 more Locations National Institutes of Health Clinical Center, 9000 Rockville Pike — Bethesda, Maryland, United States View Trial Details
Completed Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma NCT00099255 Conditions Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +14 more Locations University of Alabama at Birmingham — Birmingham, Alabama, United States University of California at Los Angeles — Los Angeles, California, United States Stanford University — Stanford, California, United States Yale — New Haven, Connecticut, United States View all 13 locations View more locations Show fewer locations Loading locations... View Trial Details
